Physician profile
Eric A Harris
NPI 1003980764
$15,514.59
in general payments reported to CMS, 2019-2025
13 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.37 · 2022: $12K · 2023: $906 · 2024: $2,631 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,057 · Food and Beverage: $1,611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,057.21 |
| Food and Beverage | $1,610.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,317.91 | 2022-2023 | Da Vinci Sp |
| Medtronic, INC. | $1,807.91 | 2021-2025 | Signia, Ligasure, Accuvac |
| Enterra Medical, INC. | $1,346.34 | 2024 | |
| Reshape Lifesciences INC. | $586.16 | 2022-2023 | |
| Novo Nordisk INC | $155.28 | 2022-2024 | Wegovy, Saxenda |
| Davol INC. | $125.52 | 2022 | |
| Mentor Worldwide LLC | $38.32 | 2022 | |
| Lilly USA, LLC | $33.38 | 2023 | Mounjaro, Zepbound |
| Currax Pharmaceuticals LLC | $28.72 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $25.47 | 2025 | |
| Allergan, INC. | $25.00 | 2021 | |
| Ethicon US, LLC | $20.12 | 2022 | |
| Heron Therapeutics, INC. | $4.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.